REGENXBIO (RGNX)
(Real Time Quote from BATS)
$8.41 USD
-0.02 (-0.24%)
Updated Feb 5, 2025 03:26 PM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RGNX 8.41 -0.02(-0.24%)
Will RGNX be a Portfolio Killer in February?
Zacks Investment Research is releasing its prediction for RGNX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RGNX
Wall Street Analysts See a 357.36% Upside in Regenxbio (RGNX): Can the Stock Really Move This High?
Regenxbio (RGNX) Reports Q3 Loss, Tops Revenue Estimates
RGNX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Regenxbio (RGNX) Could Surge 234.37%: Read This Before Placing a Bet
Regenxbio (RGNX) Reports Q2 Loss, Tops Revenue Estimates
Regenxbio (RGNX) Surges 18.3%: Is This an Indication of Further Gains?
Other News for RGNX
STATE STREET CORP Reduces Stake in Regenxbio Inc: An In-Depth Analysis
Vanguard Group Inc Reduces Stake in Regenxbio Inc
RegenXBio (RGNX) Gets a Buy from RBC Capital
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today